Complete clinical remission with tocilizumab in two infants with systemic juvenile idiopathic arthritis: a case series

Scand J Rheumatol. 2017 Jan;46(1):75-76. doi: 10.3109/03009742.2016.1164243. Epub 2016 May 24.

Authors

D N Maritsi^{1

2}, M Onoufriou², G Vartzelis¹, D Eleftheriou³

Affiliations

¹ a Second Department of Paediatrics, 'P. & A. Kyriakou' Children's Hospital, Medical Faculty , University of Athens , Athens , Greece.
² b Second Department of Paediatrics , Makarios III Children's Hospital , Nicosia , Cyprus.
³ c Department of Paediatric and Adolescent Rheumatology , Great Ormond Street Hospital , London , UK.

PMID: 27218706
DOI: 10.3109/03009742.2016.1164243

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Arthritis, Juvenile / drug therapy*
Female
Humans
Infant
Male
Remission Induction

Substances

Antibodies, Monoclonal, Humanized
tocilizumab